Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
ObvioHealth Welcomes Scott Dixon as Newest Chief Commercial Officer
ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott […]
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor […]
Digital Rehabilitation Platform Neurofenix Completes $7 Million Series A to Transform Stroke and Brain Injury Recovery
Neurofenix, the neurological rehabilitation platform that uses sensors to improve patient outcomes, has raised $7 million in […]
DiamiR Biosciences Expands Management Team with the Appointment of Fred Knechtel as its Chief Financial Officer
DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today […]
Novo Holdings Leads $50 Million Investment in MedGenome to Accelerate Expansion Into New Markets and Deepen Product Offerings
MedGenome, the leading genetic diagnostics, research, and data company in South Asia, announced today a […]
Mendus Announces Financing Commitments Totaling Up to SEK 250 Million With Van Herk Investments and Negma Group
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company addressing tumor recurrence through cell-based immunotherapies, today announces […]
PathAI Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb
PathAI, a global leader in AI-powered pathology, today announced a multi-year expanded collaboration agreement with Bristol Myers Squibb. […]
Alma Raises $130M in Series D Funding led by Thoma Bravo to Advance its Mission to Simplify Access to High Quality, Affordable Mental Health Care
Alma, a membership-based network that helps independent mental health care providers accept insurance and build […]
Avenda Health Raises $10M in Series B, Innovating Detection and Treatment for Prostate Cancer Care
Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, today […]
Marie- Andrée Gamache Appointed Country President, Novartis Innovative Medicines, UK & Ireland
Novartis UK is announcing that Marie-Andrée Gamache has been appointed to the role of Country […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more